Home › Companies › Clinical Trials, Pharmaceutical, Product Research › Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
Helmholtz Institute for Pharmaceutical Research Saarland is a research institute that focuses on the development of novel anti-infectives.
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) operates in clinical trials, pharmaceutical, product research based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2009.
The company sits in the clinical trials, pharmaceutical, product research segment, where it competes on its core product or service.
European Union (EU), Europe, Middle East, and Africa (EMEA) is where the company is located.
It is recorded at the Grant stage.
Its team size is recorded as c_00251_00500 employees.
Public records show total funding of about $1.1M.
| Sector | Clinical Trials, Pharmaceutical, Product Research |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2009 |
| Employees | c_00251_00500 |
| Stage | grant |
| Total funding | $1,060,000 |
Website: www.helmholtz-hips.de
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account